Views: 914 Author: Site Editor Publish Time: 2026-09-15 Origin: Site
Ask ten suppliers what grade of sodium hyaluronate they sell, and most will hand you a spec sheet with a molecular weight number and call it a day. But grade is not about the number on that sheet. Chemically, sodium hyaluronate is the same molecule — a sodium salt of the glycosaminoglycan hyaluronic acid — no matter which application it ends up serving.
What separates a food supplement capsule from an ophthalmic surgical aid is everything built around that molecule: how it is fermented, how thoroughly it is purified, how tightly its molecular weight is controlled, and what regulatory framework governs its production. For anyone sourcing sodium hyaluronate — whether for a new skincare line, an oral supplement, or a medical device — understanding these distinctions is the difference between choosing the right material and making an expensive mistake.
Commercially, sodium hyaluronate is sold across four application grades. Each targets a different route of exposure, and that exposure pathway drives every quality parameter downstream.
Grade | Typical MW Range | Primary Use | Purity Focus | Sterility | Regulatory Basis |
Food Grade | 0.1 – 2.0 MDa | Oral supplements, functional foods | Food safety (microbes, heavy metals) | Not required | Food additive regulations (GRAS, NMPA novel food) |
Cosmetic Grade | 3 kDa – 2.5 MDa | Serums, creams, masks, topical products | Protein residue, visual clarity | Not required (microbial limits apply) | Cosmetic regulations (EU 1223/2009, FDA, China CSAR) |
Pharmaceutical/Medical Grade | ~0.5 MDa – 2.0+ MDa | Eye drops, ophthalmic surgery viscoelastics, joint injections | Endotoxin, protein, nucleic acids | Required | Pharmacopoeia (USP/EP/JP/ChP) + medical device or drug registration |
Injectable Grade | Segmented ranges | Dermal fillers, mesotherapy, biostimulators | Strictest tier across all parameters | Mandatory, terminal or aseptic | Class III medical device (FDA PMA, NMPA III, EU MDR) |
A few things are worth noting immediately. First, molecular weight alone does not define a grade — two batches with identical average molecular weight can belong to different grades based on purity and sterility. Second, "pharmaceutical grade" and "injectable grade" are not interchangeable; the injection route demands a safety margin far beyond what topical or oral exposure requires. Third, food grade is governed by food safety law, not pharmacopoeia — a fundamentally different regulatory universe.
Hyaluronic acid has been consumed orally for decades in Japan, where it is used in functional foods (notably the branded product Hyabest). In the United States, sodium hyaluronate has received GRAS (Generally Recognized As Safe) status for use in certain food categories. In China, the National Health Commission approved sodium hyaluronate as a novel food raw material in January 2021, permitting its use in dairy products, beverages, alcoholic drinks, cocoa/chocolate products, confections, and frozen drinks at specified dosage levels, with a recommended daily intake not exceeding 200 mg.
The quality priorities for food-grade sodium hyaluronate reflect its oral route of exposure:
· Microbial limits follow food safety standards (total aerobic plate count, moulds and yeasts, pathogen absence) rather than pharmacopeial sterility requirements
· Heavy metal limits align with food additive regulations (typically lead ≤10 mg/kg)
· Protein content is controlled but to a less stringent threshold than pharmaceutical applications (≤0.1% is common)
· Molecular weight ranges broadly from ~100 kDa to 2.0 MDa, depending on the desired functional claim
The critical distinction: food-grade sodium hyaluronate is produced and tested under food safety management systems (HACCP, food GMP), not pharmaceutical GMP. The production environment, while clean, is not required to meet the particulate or bioburden standards of a sterile pharmaceutical facility. This is not a deficiency — it is an appropriate allocation of controls to the actual risk profile of oral consumption.
Cosmetic-grade sodium hyaluronate is the most commercially voluminous grade, driven by the global skincare industry's embrace of hyaluronic acid as a hero moisturizing ingredient. It is characterized by:
· Protein content typically controlled to ≤0.1%–0.5%, depending on the supplier and application
· No sterility requirement, though microbial limits apply (total plate count ≤100 CFU/g, absence of specified pathogens like E. coli and P. aeruginosa)
· No endotoxin testing requirement — the intact skin barrier makes endotoxin exposure a negligible concern for topical products
· Visual and rheological properties are important: transparency, dissolution speed, and solution viscosity are key purchasing criteria
Cosmetic formulation scientists select molecular weight based on the desired performance profile:
MW Category | Range | Primary Function |
Oligo-HA / Hydrolyzed HA | 3 – 50 kDa | Deep penetration, cellular signaling, anti-aging bioactivity |
Low MW | 50 – 400 kDa | Moderate penetration, moisturizing + bioactivity |
Medium MW | 400 – 1,000 kDa | Surface moisturizing, film-forming |
High MW | 1,000 – 2,000+ kDa | Strong film-forming, viscoelastic cushioning, sustained hydration |
The industry trend is toward multi-molecular-weight blends — combining high, medium, and low molecular weight fractions in a single formulation to deliver layered hydration from surface to deeper epidermal layers. Research has shown that molecules below 300 kDa (and especially below 50 kDa) exhibit measurable anti-aging bioactivity, including stimulation of collagen synthesis and reduction in wrinkle depth.
Beyond native sodium hyaluronate, the cosmetic industry has developed several derivatives:
· Hydrolyzed Sodium Hyaluronate: Enzymatically cleaved low-MW fractions for improved skin penetration
· Sodium Acetylated Hyaluronate: Acetylation introduces both hydrophilic and lipophilic character, improving skin adhesion and barrier repair
· Hydroxypropyltrimonium Hyaluronate: Cationic modification for enhanced substantivity to hair and skin
· Crosslinked Sodium Hyaluronate: Creates a resilient, breathable film on the skin surface for long-lasting hydration
These derivatives have created what industry observers call the "second" and "third generation" of HA ingredients in cosmetics — moving beyond simple moisturizing into bioactive and functional territory.
When sodium hyaluronate crosses the skin barrier — entering the eye, a joint cavity, or a surgical wound — the quality requirements shift dramatically. Pharmaceutical and medical-grade sodium hyaluronate encompasses two primary sub-categories:
Used in eye drops, ophthalmic viscosurgical devices (OVDs) for cataract surgery, contact lens solutions, and corneal repair products. Key specifications include:
· Endotoxin: ≤0.5 EU/mg (European Pharmacopoeia), with leading manufacturers targeting <0.1 EU/mg in practice
· Protein: ≤0.1%
· Sterility: Required, typically achieved through sterile filtration (0.22 μm) and aseptic processing
· Molecular weight: Varies by application — ophthalmic solutions typically use 500 kDa – 1,500 kDa; viscosurgical devices require higher MW for viscoelastic performance
Used in intra-articular injections for osteoarthritis treatment (viscosupplementation), post-surgical anti-adhesion barriers, and wound healing applications:
· Purity: Meets pharmacopoeial standards with additional controls on nucleic acid residue and specific impurities
· Sterility: Mandatory, with terminal sterilization preferred where the molecule can withstand it
· Molecular weight control: Tighter distribution bandwidth than cosmetic grade, since MW directly affects viscoelastic behavior in the joint
Pharmaceutical-grade sodium hyaluronate is governed by official monographs in major pharmacopoeias:
· USP (United States Pharmacopeia)
· EP (European Pharmacopoeia)
· JP (Japanese Pharmacopoeia)
· ChP (Chinese Pharmacopoeia)
These monographs define minimum acceptance criteria for identity, purity, molecular weight, protein content, and microbial quality. While the core requirements are harmonized, there are meaningful differences — for example, the European Pharmacopoeia specifies an endotoxin limit of ≤0.5 EU/mg for sodium hyaluronate intended for parenteral use, while other pharmacopoeias may reference this differently. Manufacturers targeting multiple markets must satisfy the most stringent applicable standard.
Injectable-grade sodium hyaluronate — used in dermal fillers, mesotherapy, and biostimulators — represents the highest quality tier. The rationale is straightforward: injection bypasses every one of the body's natural protective barriers. Material that enters the dermis, subcutaneous tissue, or joint space directly contacts living cells and the immune system. Even trace contamination can trigger inflammation, granuloma formation, or systemic immune reactions.
The specifications reflect this reality:
· Endotoxin: The pharmacopoeial limit of ≤0.5 EU/mg is the ceiling; leading injectable-grade manufacturers routinely achieve levels an order of magnitude below this threshold
· Sterility assurance: Terminal sterilization (autoclaving the final sealed product) is the gold standard; where the molecule cannot withstand heat, aseptic processing through the entire manufacturing chain becomes mandatory
· Crosslinking: Most injectable HA products use chemical crosslinking agents (most commonly BDDE — 1,4-butanediol diglycidyl ether) to convert linear HA into a three-dimensional gel network that resists enzymatic degradation, extending persistence in tissue from days to 8–18 months
· Regulatory classification: Injectable fillers are Class III medical devices in virtually every major jurisdiction — FDA PMA in the United States, Class III under China's NMPA, and Class III under the EU MDR — requiring the most rigorous pre-market review, including clinical data
The manufacturing requirements for injectable grade create a natural bottleneck. Not every facility that produces cosmetic-grade or even ophthalmic-grade sodium hyaluronate has the infrastructure, cleanroom classification, or regulatory documentation to produce injectable material. This is the single most important factor distinguishing capable suppliers from the broader market.
Selecting the correct grade of sodium hyaluronate is not a matter of buying the "best" or "most expensive" option — it is about matching material properties to your product's route of exposure, target market regulations, and performance requirements.
Step 1: What is the final product?
· Oral supplement or functional food → Food Grade
· Topical skincare, haircare, or cosmetic → Cosmetic Grade
· Eye drop, ophthalmic device, or wound care → Pharmaceutical/Medical Grade (Ophthalmic)
· Dermal filler, joint injection, or subcutaneous implant → Injectable Grade
Step 2: What market are you selling into?
· Different markets have different pharmacopoeial and regulatory requirements. A sodium hyaluronate that meets USP may need additional testing for EP compliance. Ensure your supplier can provide documentation for your target jurisdiction.
Step 3: What molecular weight does your application need?
· High MW (>1,000 kDa) → surface film-forming, viscoelastic cushioning
· Medium MW (400–1,000 kDa) → balanced moisturizing
· Low MW (50–400 kDa) → penetration + bioactivity
· Oligo (<50 kDa) → deep cellular interaction
Step 4: Evaluate your supplier
Capability | Why It Matters |
Multi-grade production capability | Ensures consistent quality across your product portfolio |
In-house fermentation + purification | Direct control over quality; not dependent on third-party supply |
Molecular weight customization | Ability to tailor MW to your specific application |
Full regulatory documentation (DMF, CEP, ISO 13485, COSMOS) | Accelerates your own product registration |
Batch traceability and comprehensive COA | Essential for regulatory audits and quality investigations |
Cleanroom classification appropriate to grade | Cosmetic grade does not require ISO 5, but injectable grade does |
"Cosmetic grade and pharmaceutical grade are the same molecule, so they're interchangeable." They are the same molecule, but the purity, sterility, and documentation requirements are fundamentally different. Using cosmetic-grade material in an injectable product is illegal in virtually every jurisdiction and can cause serious patient harm.
"Higher molecular weight is always better." Each application has an optimal MW range. High MW creates viscosity that is desirable in viscosurgical devices but counterproductive in a fast-absorbing serum.
"Food grade means it's safe for any use." Food safety standards address oral consumption risks, not injection or ophthalmic risks. The regulatory frameworks are entirely separate.
The distance between food-grade and injectable-grade sodium hyaluronate is not measured in millimeters — it is measured in years of process development, cleanroom infrastructure, regulatory investment, and quality culture. A manufacturer that can reliably produce across all four grades demonstrates mastery of the entire value chain, from strain selection and fermentation optimization through multi-stage purification, aseptic processing, and regulatory documentation.
This is the dimension that separates commodity suppliers from strategic partners. A company like Shandong Runxin Biotechnology, with 28 years of dedicated hyaluronic acid manufacturing experience, exemplifies this full-spectrum capability. Runxin produces across all four grades — food, cosmetic, ophthalmic, and injectable — from a single integrated manufacturing platform. Their facility holds a comprehensive certification portfolio including ISO 13485, CE, DMF (036368), COSMOS, HALAL, and cGMP, covering the regulatory requirements of major global markets. With in-house fermentation, multi-stage purification, and aseptic filling capabilities, combined with export experience across 34 countries, Runxin offers the kind of end-to-end quality assurance that sophisticated buyers need when their product's safety profile depends on the raw material.
Choosing the right grade of sodium hyaluronate is the starting point. Choosing the right manufacturer who can deliver that grade consistently, with documentation and compliance, is what turns a good product into a safe, registrable, marketable one.
Looking for a sodium hyaluronate supplier who can meet your exact grade requirements? Contact Runxin Biotechnology to discuss your application needs and discover how our full-spectrum manufacturing capability — from food grade to injectable grade — can support your product development from concept to market.
